Insider Transactions in Q3 2021 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.68%
|
$140,220
$36.88 P/Share
|
|
Sep 15
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Sep 14
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.69%
|
$140,220
$36.93 P/Share
|
|
Sep 14
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Sep 13
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.68%
|
$144,115
$37.64 P/Share
|
|
Sep 13
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Sep 10
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.15%
|
$190,000
$38.73 P/Share
|
|
Sep 09
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
24,753
-1.45%
|
$940,614
$38.42 P/Share
|
|
Sep 08
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
13,746
-0.4%
|
$522,348
$38.73 P/Share
|
|
Sep 08
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-18.79%
|
$195,000
$39.01 P/Share
|
|
Sep 08
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+15.82%
|
$35,000
$7.27 P/Share
|
|
Sep 07
2021
|
Stacy L Taylor SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
495
-3.19%
|
$19,800
$40.0 P/Share
|
|
Sep 07
2021
|
Stacy L Taylor SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
495
+3.09%
|
$2,970
$6.55 P/Share
|
|
Sep 07
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,375
-30.26%
|
$365,625
$39.71 P/Share
|
|
Sep 07
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+23.23%
|
$56,250
$6.55 P/Share
|
|
Aug 27
2021
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
14,916
-90.84%
|
$522,060
$35.0 P/Share
|
|
Aug 27
2021
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,916
+47.6%
|
$104,412
$7.8 P/Share
|
|
Aug 27
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.69%
|
$132,430
$34.58 P/Share
|
|
Aug 27
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Aug 26
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-5.32%
|
$128,535
$33.89 P/Share
|
|
Aug 26
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Aug 25
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-5.32%
|
$132,430
$34.09 P/Share
|
|
Aug 25
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Aug 16
2021
|
Nitin Sood Chief Commercial Officer, MRD |
BUY
Grant, award, or other acquisition
|
Direct |
97,213
+50.0%
|
-
|
|
Aug 11
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-16.58%
|
$330,000
$33.98 P/Share
|
|
Aug 11
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$60,000
$6.55 P/Share
|
|
Aug 10
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-18.79%
|
$175,000
$35.0 P/Share
|
|
Aug 10
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+15.82%
|
$30,000
$6.55 P/Share
|
|
Jul 21
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.69%
|
$144,115
$37.7 P/Share
|
|
Jul 21
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Jul 20
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.69%
|
$144,115
$37.32 P/Share
|
|
Jul 20
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Jul 19
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.69%
|
$144,115
$37.02 P/Share
|
|
Jul 19
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Jul 19
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
SELL
Open market or private sale
|
Direct |
651
-6.64%
|
$23,436
$36.12 P/Share
|
|
Jul 19
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
BUY
Exercise of conversion of derivative security
|
Direct |
651
+6.22%
|
$14,322
$22.55 P/Share
|
|
Jul 14
2021
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
2,500
-62.44%
|
$90,000
$36.8 P/Share
|
|
Jul 14
2021
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+38.44%
|
$17,500
$7.8 P/Share
|
|
Jul 12
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
1,501
-0.09%
|
$57,038
$38.24 P/Share
|
|
Jul 08
2021
|
R Mark Adams Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,254
-3.94%
|
$81,144
$36.3 P/Share
|
|
Jul 07
2021
|
R Mark Adams Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
871
-1.5%
|
$33,969
$39.42 P/Share
|
|
Jul 07
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-17.26%
|
$380,000
$38.68 P/Share
|
|
Jul 07
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$60,000
$6.55 P/Share
|
|
Jul 06
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-31.64%
|
$380,000
$38.83 P/Share
|
|
Jul 06
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$60,000
$6.55 P/Share
|